206 related articles for article (PubMed ID: 33412421)
1. The long and winding road of designing phosphodiesterase inhibitors for the treatment of heart failure.
Nadur NF; de Azevedo LL; Caruso L; Graebin CS; Lacerda RB; Kümmerle AE
Eur J Med Chem; 2021 Feb; 212():113123. PubMed ID: 33412421
[TBL] [Abstract][Full Text] [Related]
2. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
Truss MC; Uckert S; Stief CG; Schulz-Knappe P; Hess R; Forssmann WG; Jonas U
Urology; 1995 May; 45(5):893-901. PubMed ID: 7747383
[TBL] [Abstract][Full Text] [Related]
3. Carboxyamidotriazole: a novel inhibitor of both cAMP-phosphodiesterases and cGMP-phosphodiesterases.
Guo L; Luo L; Ju R; Chen C; Zhu L; Li J; Yu X; Ye C; Zhang D
Eur J Pharmacol; 2015 Jan; 746():14-21. PubMed ID: 25446933
[TBL] [Abstract][Full Text] [Related]
4. Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation.
Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
Cell Mol Biol Lett; 2005; 10(2):305-19. PubMed ID: 16010295
[TBL] [Abstract][Full Text] [Related]
5. Cardiac Phosphodiesterases and Their Modulation for Treating Heart Disease.
Kim GE; Kass DA
Handb Exp Pharmacol; 2017; 243():249-269. PubMed ID: 27787716
[TBL] [Abstract][Full Text] [Related]
6. Identification of substrate specificity determinants in human cAMP-specific phosphodiesterase 4A by single-point mutagenesis.
Richter W; Unciuleac L; Hermsdorf T; Kronbach T; Dettmer D
Cell Signal; 2001 Mar; 13(3):159-67. PubMed ID: 11282454
[TBL] [Abstract][Full Text] [Related]
7. Nanodomain Regulation of Cardiac Cyclic Nucleotide Signaling by Phosphodiesterases.
Kokkonen K; Kass DA
Annu Rev Pharmacol Toxicol; 2017 Jan; 57():455-479. PubMed ID: 27732797
[TBL] [Abstract][Full Text] [Related]
8. ABCD of the phosphodiesterase family: interaction and differential activity in COPD.
Halpin DM
Int J Chron Obstruct Pulmon Dis; 2008; 3(4):543-61. PubMed ID: 19281073
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone down-regulates cAMP-phosphodiesterase in human osteosarcoma cells.
Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
Biochem Pharmacol; 2005 Jan; 69(2):267-75. PubMed ID: 15627479
[TBL] [Abstract][Full Text] [Related]
10. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
Torphy TJ; Cieslinski LB
Mol Pharmacol; 1990 Feb; 37(2):206-14. PubMed ID: 2154670
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of cyclic nucleotide phosphodiesterase inhibitors in heart failure.
Movsesian MA
Expert Opin Investig Drugs; 2000 May; 9(5):963-73. PubMed ID: 11060720
[TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase inhibitors.
Boswell-Smith V; Spina D; Page CP
Br J Pharmacol; 2006 Jan; 147 Suppl 1(Suppl 1):S252-7. PubMed ID: 16402111
[TBL] [Abstract][Full Text] [Related]
13. Cyclic nucleotide phosphodiesterases (PDEs) and endothelial function in ischaemic stroke. A review.
Yasmeen S; Akram BH; Hainsworth AH; Kruuse C
Cell Signal; 2019 Sep; 61():108-119. PubMed ID: 31132399
[TBL] [Abstract][Full Text] [Related]
14. Basic and clinical characteristics of PDE 3 inhibitors as cardiotonic agents.
Endoh M
Cardiovasc Drugs Ther; 2007 Jun; 21(3):135-9. PubMed ID: 17508272
[No Abstract] [Full Text] [Related]
15. Cardiac Cyclic Nucleotide Phosphodiesterases: Roles and Therapeutic Potential in Heart Failure.
Preedy MEJ
Cardiovasc Drugs Ther; 2020 Jun; 34(3):401-417. PubMed ID: 32172427
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase inhibitors in airways disease.
Fan Chung K
Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
[TBL] [Abstract][Full Text] [Related]
17. Syntheses and evaluation of pyrido[2,3-dlpyrimidine-2,4-diones as PDE 4 inhibitors.
Nam G; Yoon CM; Kim E; Rhee CK; Kim JH; Shin JH; Kim SH
Bioorg Med Chem Lett; 2001 Mar; 11(5):611-4. PubMed ID: 11266153
[TBL] [Abstract][Full Text] [Related]
18. cAMP-specific phosphodiesterase inhibitors: promising drugs for inflammatory and neurological diseases.
Martinez A; Gil C
Expert Opin Ther Pat; 2014 Dec; 24(12):1311-21. PubMed ID: 25284693
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterases Expression during Murine Cardiac Development.
Carvalho TMDCS; Cardarelli S; Giorgi M; Lenzi A; Isidori AM; Naro F
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807511
[TBL] [Abstract][Full Text] [Related]
20. Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets.
Ahmad F; Murata T; Shimizu K; Degerman E; Maurice D; Manganiello V
Oral Dis; 2015 Jan; 21(1):e25-50. PubMed ID: 25056711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
